LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Awareness Technology Showcases Range of Cutting-Edge Analyzers

By LabMedica International staff writers
Posted on 12 Nov 2024
Print article
Image: The new Chemi+ biochemistry analyzer is available for a hands-on demonstration at MEDICA 2024 (Photo courtesy of Awareness Technology)
Image: The new Chemi+ biochemistry analyzer is available for a hands-on demonstration at MEDICA 2024 (Photo courtesy of Awareness Technology)

Awareness Technology, Inc. (Palm City, FL, USA) is showcasing its advanced analyzers at MEDICA 2024 where these instruments are available for hands-on demonstrations during the show.

At this year’s MEDICA, Awareness is presenting the ChemWell 2 two-plate ELISA/chemiluminescent analyzer for running a variety of applications. The instrument’s ability to mix a wide range of ELISA/CLIA assays on two microwell plates provides a level of flexibility that makes the ChemWell 2 an excellent choice for laboratories. Awareness is also showcasing the ChemWell RPR Automated RRP Analyzer for serum syphilis screening that utilizes a sophisticated camera system designed to capture high-resolution images of the reactions. It features specialized software that analyzes the image, providing an accurate and objective reading of the reaction as reactive or non-reactive.

Also being presented at the show are the enhanced Stat Fax 4500 biochemistry analyzer and Stat Fax 4700 ELISA strip reader which have recently received upgraded screens, faster processors, and new user interfaces. At the heart of the Stat Fax 4500 and 4700 is a new and faster micro-processor and significantly increased memory capacity. All the calculation modes, reporting functions, and the ability to customize test parameters remain the same but function faster. A new feature of the instruments’ improved memory capacity is their ability to store over 140 programmed tests. Their new interface features a high-resolution backlit display with a capacitive touch screen that has the responsiveness of a smartphone with no need for a stylus to make accurate selections. Screens are updated almost instantly with a new menu system driven by icons designed to intuitively identify their functions.

At MEDICA 2024, Awareness is also introducing its latest instrument, the Chemi+ biochemistry analyzer designed to optimize laboratory efficiency. This compact device boasts a small footprint, making it an ideal choice for labs with limited space. The Chemi+ is complemented by user-friendly software, ensuring seamless operation for lab technicians of all skill levels. A standout feature of the Chemi+ is its open system capability, which allows for wireless management of up to four Chemi+ analyzers through a single tablet or PC. This integration not only simplifies workflow but also enhances productivity by enabling simultaneous multi-device operation. The Chemi+ biochemistry analyzer is poised to set a new standard in laboratory technology, combining efficiency, ease of use, and advanced connectivity in a compact design.

Related Links:
Awareness Technology, Inc.

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.